Joshua Pinto, President of Neumora Therapeutics ($NMRA), made one open market sale of common shares in the last year, totaling about $21 thousand. His most recent transaction occurred on February 17, 2026. This places him in 11,006th position among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | S | Common Stock | 5967 | $3.54 | 209,950.0000 | 167,089,114 | 2.76% | 0.00% |
| Jan. 8, 2026 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 1200000 | $0.00 | 1,200,000.0000 | 167,089,114 | 9999.99% | 0.72% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | D | Stock Option (right to buy) | 148953 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.14% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | D | Stock Option (right to buy) | 16125 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.02% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | A | Restricted Stock Unit | 2688 | $0.00 | 2,688.0000 | 105,376,189 | 9999.99% | 0.00% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | D | Common Stock | 2688 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.00% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 3000000 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 1.85% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 223034 | $0.00 | 223,034.0000 | 161,978,923 | 9999.99% | 0.14% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 270828 | $0.00 | 270,828.0000 | 161,978,923 | 9999.99% | 0.17% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 223034 | $0.00 | 223,034.0000 | 161,978,923 | 9999.99% | 0.14% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 223034 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.14% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 127448 | $0.00 | 127,448.0000 | 161,978,923 | 9999.99% | 0.08% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 161,978,923 | 9999.99% | 0.10% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 3000000 | $0.00 | 3,000,000.0000 | 161,978,923 | 9999.99% | 1.85% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 720084 | $0.00 | 720,084.0000 | 161,978,923 | 9999.99% | 0.44% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 270828 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.17% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 223034 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.14% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 720084 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.44% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 127448 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.08% |
| May 28, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 170000 | $0.00 | 0.0000 | 161,978,923 | 100.00% | 0.10% |
| May 21, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | G | Common Stock | 13202 | $0.00 | 215,917.0000 | 161,978,923 | 5.76% | 0.01% |
| May 21, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | G | Common Stock | 13202 | $0.00 | 215,917.0000 | 161,978,923 | 6.51% | 0.01% |
| May 22, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | G | Stock Option (Right to Buy) | 148953 | $0.00 | 148,953.0000 | 105,050,219 | 9999.99% | 0.14% |
| May 22, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | G | Stock Option (Right to Buy) | 148953 | $0.00 | 148,953.0000 | 105,050,219 | 50.00% | 0.14% |
| May 20, 2025 | Metsera, Inc. | $MTSR | Pinto Joshua | Not found | A | Stock Option (Right to Buy) | 16125 | $0.00 | 165,078.0000 | 105,050,219 | 10.83% | 0.02% |
| Feb. 18, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | S | Common Stock | 8048 | $1.67 | 215,917.0000 | 0 | 3.59% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 223034 | $0.00 | 223,034.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 720084 | $0.00 | 720,084.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 127448 | $0.00 | 127,448.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 223034 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 720084 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 127448 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 170000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 223034 | $0.00 | 223,034.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 270828 | $0.00 | 270,828.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 270828 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | D | Stock Option (Right to Buy) | 223034 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 13, 2025 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | President | A | Stock Option (Right to Buy) | 3000000 | $0.00 | 3,000,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | S | Common Stock | 15693 | $11.39 | 223,965.0000 | 0 | 6.55% | 0.00% |
| Aug. 23, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | S | Common Stock | 24169 | $11.59 | 271,300.0000 | 0 | 8.18% | 0.00% |
| Aug. 22, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | S | Common Stock | 28496 | $11.63 | 295,469.0000 | 0 | 8.80% | 0.00% |
| Aug. 26, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | S | Common Stock | 31642 | $11.78 | 239,658.0000 | 0 | 11.66% | 0.00% |
| April 17, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | G | Common Stock | 238965 | $0.00 | 323,965.0000 | 0 | 42.45% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Pinto Joshua | Chief Financial Officer | A | Common Stock | 85000 | $0.00 | 323,965.0000 | 0 | 35.57% | 0.00% |